'Unclear for GPs': Blurred referral lines blight breast cancer care

GPs are in the dark on which specialists their breast cancer patients should be referred to for risk-reducing medications such as the newly PBS-listed tamoxifen.

Specialists themselves are confused as to who should take responsibility for prescribing the therapy, according to survey findings presented at the Clinical Oncology Society of Australia’s annual scientific meeting on the Gold Coast this week.

Dr Sarah Sutherland, an oncology trainee and research fellow at the Concord Repatriation General Hospital, Sydney,